<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20220524054977N2</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2022-09-13</date_registration>
      <primary_sponsor>Shifa Tameer-e-millat university</primary_sponsor>
      <public_title>Effectiveness of Electrical Muscle Stimulation versus Resisted Exercises in upper limbs muscle Strength and bulk development in paraplegic patients</public_title>
      <acronym></acronym>
      <scientific_title>Effectiveness of Electrical Muscle Stimulation versus Resisted Exercises in upper limbs muscle Strength and bulk development in paraplegic patients</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2022-01-03</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>52</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/65747</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: After patients are selected and baseline similarities are assessed, they will be randomly allocated to the control group and experimental group using the sealed envolpe method, Blinding description: Due to the nature of the study, it will not be feasible to blind the researcher/therapist and subjects. However, the assessor, who will assess pre and post scores, will be blinded.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Paraplagia.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: This group was provided with electrical muscle stimulation intervention. Participants undergone the overall treatment session for two months (8 weeks) and 3 days per week. The targeted muscles for electrical stimulation were bicep brachi and triceps brachi. The parameters were as follows, frequency 45 Hertz, Biphasic Symmetrical Square wave with10 second on and 20 second off time. Ramp up time was 3 second, while ramp down timeWas 3 seconds. We used Comfy Stim EV-806 for muscle stimulation. Synchronous Stimulation was applied. The total electrical stimulation time was 10 minutes for each Muscle. The intensity at which tetanic contraction was elicited was used. Two of the EMS electrodes pad was placed on belly and insertion of Bicep muscles and then on Triceps muscles respectively. Intervention 2: Control group: This group were underwent resisted exercises for 8 weeks. The maximum strength of participants was assessed by one repetition maximum before and after the training session. Two exercises were included: Seated chest press involving pectoralis major and pectoralis minor, triceps brachii and deltoid muscles and Seated arm pull involving latissimus dorsi, trapezius, teres major and minor, rhomboids, deltoids, biceps brachii and brachialis, triceps brachii, pectoralis major and minor, and serratus anterior muscles. During each training session 3 sets were performed. The intensity of these sets was 80% of one repetition maximum. In first and second set, 8 repetitions were performed of two included exercises. In next third set patient will perform repetitions up to muscle fatigue level. If patient were able to perform 12 or more repetitions while performing third set, then work load were increased 5-10% for next treatment session. Two minutes’ rest was given after each set performed and 5-minute rest in between both exercises. The concentric and eccentric phases of resistance will last for 3 second each.  Every training session were started and ended at heart rate of 100 beats per minutes whereas stretching time of 5 minutes.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>No - There is not a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for not sharing IPD is To keep the privacy of the participants</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Syed Ali Hussain</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Shifa International Hospitals Ltd، Gate No. 1، 4 Pitras Bukhari Rd, H 8/4 H-8, Islamabad, Islamabad Capital Territory</address>
        <city>Islamabad</city>
        <country1>Pakistan</country1>
        <zip>44000</zip>
        <telephone>+92 51 8438060</telephone>
        <email>alihussain_dpt.ads@stmu.edu.pk</email>
        <affiliation>shifa tameer-e-millat university</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Habib Ullah</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Shifa International Hospitals Ltd، Gate No. 1، 4 Pitras Bukhari Rd, H 8/4 H-8, Islamabad, Islamabad Capital Territory</address>
        <city>Islamabad</city>
        <country1>Pakistan</country1>
        <zip>44000</zip>
        <telephone>+92 51 8438060</telephone>
        <email>habibullah65464@gmail.com</email>
        <affiliation>Shifa Tameer-e-Millat University</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Pakistan</country2>
    </countries>
    <criteria>
      <inclusion_criteria>If participants have a sustained spinal cord injury from four weeks and their primary rehabilitation is completed
Age including 18-30 years
Participants that are able to give consent
Participants that are labeled by their physician as fit and can undertake exercise training program Ischemic stroke of MCA subjects suffering from stroke for at least 6 months</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>30 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>If the patient will have Brachial plexus, peripheral nerve injury or current surgery of upper limb since last 2 months
According to the National Pressure Ulcer Advisory Panel classification. Have stage 3 or 4 sacral ulcer
Have any bone disorder e.g. such as Paget’s disease, senile osteoporosis etc
Have a long-term history of fractures in the upper limb.
Have a family history of weakened fractures
Suffering from chronic systemic diseases, e.g. hepatitis C or HIV-AIDS
Have fixed contractures in the upper extremity
Have already pain in upper limb due to any other cause rather than SCI
Are likely to experience autonomic hyperreflexia
Could suffer from orthostatic hypotension as a result of electrical muscle stimulation
Have any other serious medical conditions like malignancies, psychiatric problems</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>G82.2</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Paraplegia</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Rehabilitation</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: This group was provided with electrical muscle stimulation intervention. Participants undergone the overall treatment session for two months (8 weeks) and 3 days per week. The targeted muscles for electrical stimulation were bicep brachi and triceps brachi. The parameters were as follows, frequency 45 Hertz, Biphasic Symmetrical Square wave with10 second on and 20 second off time. Ramp up time was 3 second, while ramp down timeWas 3 seconds. We used Comfy Stim EV-806 for muscle stimulation. Synchronous Stimulation was applied. The total electrical stimulation time was 10 minutes for each Muscle. The intensity at which tetanic contraction was elicited was used. Two of the EMS electrodes pad was placed on belly and insertion of Bicep muscles and then on Triceps muscles respectively.</i_keyword>
      <i_keyword>Control group: This group were underwent resisted exercises for 8 weeks. The maximum strength of participants was assessed by one repetition maximum before and after the training session. Two exercises were included: Seated chest press involving pectoralis major and pectoralis minor, triceps brachii and deltoid muscles and Seated arm pull involving latissimus dorsi, trapezius, teres major and minor, rhomboids, deltoids, biceps brachii and brachialis, triceps brachii, pectoralis major and minor, and serratus anterior muscles. During each training session 3 sets were performed. The intensity of these sets was 80% of one repetition maximum. In first and second set, 8 repetitions were performed of two included exercises. In next third set patient will perform repetitions up to muscle fatigue level. If patient were able to perform 12 or more repetitions while performing third set, then work load were increased 5-10% for next treatment session. Two minutes’ rest was given after each set performed and 5-minute rest in between both exercises. The concentric and eccentric phases of resistance will last for 3 second each.  Every training session were started and ended at heart rate of 100 beats per minutes whereas stretching time of 5 minutes.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Muscle Strength. Timepoint: Before intervention, as baseline, and after 8 weeks of intervention. Method of measurement: 3.3.1	MMT (manual muscle testing) or Oxford Scale.</prim_outcome>
      <prim_outcome>Muscle size. Timepoint: Baseline and after 8 weeks of intervention. Method of measurement: Measuring Tape.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Shifa Tameer-e-millat university</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2022-01-02</approval_date>
        <contact_name>Institutional Review Board (IRB) of Shifa Tameer-e-Millat University</contact_name>
        <contact_address>Shifa International Hospitals Ltd، Gate No. 1، 4 Pitras Bukhari Rd, H 8/4 H-8, Islamabad, Islamabad Capital Territory Islamabad Capital Pakistan</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
